vimarsana.com
Home
Live Updates
Crossject reports audited financial results for 2023 : comparemela.com
Crossject reports audited financial results for 2023
Dijon, France April 25, 2024 -- Crossject (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharmaceuticals company developing products for emergency...
Related Keywords
Natasha Drapeau ,
Sophie Baumont ,
Us Biomedical Advanced Research ,
Development Authority ,
Euronext ,
Research Tax Credit ,
Cohesion Bureau ,
France April ,
Advanced Research ,
Paris Stock Exchange Alcj ,
Crossject ,
comparemela.com © 2020. All Rights Reserved.